1
|
Santi C, Scimmi C, Sancineto L. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation. Molecules 2021; 26:4230. [PMID: 34299505 PMCID: PMC8306772 DOI: 10.3390/molecules26144230] [Citation(s) in RCA: 56] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 07/07/2021] [Accepted: 07/09/2021] [Indexed: 02/06/2023] Open
Abstract
Ebselen is the leader of selenorganic compounds, and starting from its identification as mimetic of the key antioxidant enzyme glutathione peroxidase, several papers have appeared in literature claiming its biological activities. It was the subject of several clinical trials and it is currently in clinical evaluation for the treatment of COVID-19 patients. Given our interest in the synthesis and pharmacological evaluation of selenorganic derivatives with this review, we aimed to collect all the papers focused on the biological evaluation of ebselen and its close analogues, covering the timeline between 2016 and most of 2021. Our analysis evidences that, even if it lacks specificity when tested in vitro, being able to bind to every reactive cysteine, it proved to be always well tolerated in vivo, exerting no sign of toxicity whatever the administered doses. Besides, looking at the literature, we realized that no review article dealing with the synthetic approaches for the construction of the benzo[d][1,2]-selenazol-3(2H)-one scaffold is available; thus, a section of the present review article is completely devoted to this specific topic.
Collapse
Affiliation(s)
| | | | - Luca Sancineto
- Group of Catalysis and Green Organic Chemistry, Department of Pharmaceutical Sciences, University of Perugia Via del Liceo 1, 06122 Perugia, Italy; (C.S.); (C.S.)
| |
Collapse
|
2
|
Zhang DW, Yan HL, Xu XS, Xu L, Yin ZH, Chang S, Luo H. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75. J Enzyme Inhib Med Chem 2020; 35:906-912. [PMID: 32228103 PMCID: PMC7170385 DOI: 10.1080/14756366.2020.1743282] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Lens-epithelium-derived growth-factor (LEDGF/p75)-binding site on HIV-1 integrase (IN), is an attractive target for antiviral chemotherapy. Small-molecule compounds binding to this site are referred as LEDGF-IN inhibitors (LEDGINs). In this study, compound libraries were screened to identify new inhibitors of LEDGF/p75-IN interaction. Ebselen (2-phenyl-1,2-benzisoselenazol-3-one), a reported anti-HIV-1 agent, was identified as a moderate micromolar inhibitor of LEDGF/p75-IN interaction. Ebselen inhibited the interaction by binding to LEDGF/p75 and the ability of ebselen to inhibit the interaction could be reversed by dithiothreitol (DTT). BLI experiment showed that ebselen probably formed selenium-sulphur bonds with reduced thiols in LEDGF/p75. To the best of our knowledge, we showed for the first time that small-molecule compound, ebselen inhibited LEDGF/p75-IN interaction by directly binding to LEDGF/p75. The compound discovered here could be used as probe compounds to design and develop new disrupter of LEDGF/p75-IN interaction.
Collapse
Affiliation(s)
- Da-Wei Zhang
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China
| | - Hao-Li Yan
- Center for Food and Drug Evaluation & Inspection of Henan, Zhengzhou, China
| | - Xiao-Shuang Xu
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China
| | - Lei Xu
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China
| | - Zhi-Hui Yin
- First Hospital of Shanxi Medical University, Taiyuan, China
| | - Shan Chang
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China
| | - Heng Luo
- College of Life Sciences, South-Central University for Nationalities, Wuhan, China
| |
Collapse
|
3
|
Abstract
Ebselen is a synthetic organoselenium radical scavenger compound that possesses glutathione peroxidase-like activity and its own unique bioactivity by reacting with thiols, hydroperoxides and peroxynitrites. Owing to its high affinity toward several essential reactions, ebselen protects cellular components from oxidative and free radical damage, and it has been employed as a useful tool for studying redox-related mechanisms. Based on numerous in vitro and in vivo research, mechanisms are proposed to understand the biomedical and molecular actions of ebselen in health and disease, and it is currently under clinical trials for the prevention and treatment of various human disorders. Based on these outstanding discoveries, this review summarizes the current understanding of the biochemical and molecular characteristics, pharmacological applications and future directions of ebselen.
Collapse
|
4
|
Zhang J, Saad R, Taylor EW, Rayman MP. Selenium and selenoproteins in viral infection with potential relevance to COVID-19. Redox Biol 2020; 37:101715. [PMID: 32992282 PMCID: PMC7481318 DOI: 10.1016/j.redox.2020.101715] [Citation(s) in RCA: 104] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Revised: 09/03/2020] [Accepted: 09/05/2020] [Indexed: 02/07/2023] Open
Abstract
Selenium is a trace element essential to human health largely because of its incorporation into selenoproteins that have a wide range of protective functions. Selenium has an ongoing history of reducing the incidence and severity of various viral infections; for example, a German study found selenium status to be significantly higher in serum samples from surviving than non-surviving COVID-19 patients. Furthermore, a significant, positive, linear association was found between the cure rate of Chinese patients with COVID-19 and regional selenium status. Moreover, the cure rate continued to rise beyond the selenium intake required to optimise selenoproteins, suggesting that selenoproteins are probably not the whole story. Nonetheless, the significantly reduced expression of a number of selenoproteins, including those involved in controlling ER stress, along with increased expression of IL-6 in SARS-CoV-2 infected cells in culture suggests a potential link between reduced selenoprotein expression and COVID-19-associated inflammation. In this comprehensive review, we describe the history of selenium in viral infections and then go on to assess the potential benefits of adequate and even supra-nutritional selenium status. We discuss the indispensable function of the selenoproteins in coordinating a successful immune response and follow by reviewing cytokine excess, a key mediator of morbidity and mortality in COVID-19, and its relationship to selenium status. We comment on the fact that the synthetic redox-active selenium compound, ebselen, has been found experimentally to be a strong inhibitor of the main SARS-CoV-2 protease that enables viral maturation within the host. That finding suggests that redox-active selenium species formed at high selenium intake might hypothetically inhibit SARS-CoV-2 proteases. We consider the tactics that SARS-CoV-2 could employ to evade an adequate host response by interfering with the human selenoprotein system. Recognition of the myriad mechanisms by which selenium might potentially benefit COVID-19 patients provides a rationale for randomised, controlled trials of selenium supplementation in SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Jinsong Zhang
- Key Laboratory of Tea Plant Biology and Utilization, School of Tea & Food Science, Anhui Agricultural University, 130 West Changjiang Road, Hefei, 230036, Anhui, PR China
| | - Ramy Saad
- Department of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK; Royal Sussex County Hospital, Brighton, BN2 5BE, UK
| | - Ethan Will Taylor
- Department of Chemistry and Biochemistry, University of North Carolina Greensboro, Greensboro, NC 27402, USA
| | - Margaret P Rayman
- Department of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7XH, UK.
| |
Collapse
|
5
|
Nguyen TB. Recent Advances in the Synthesis of Heterocycles via Reactions Involving Elemental Sulfur. Adv Synth Catal 2020. [DOI: 10.1002/adsc.202000535] [Citation(s) in RCA: 63] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Thanh Binh Nguyen
- Institut de Chimie des Substances NaturellesCNRS UPR 2301Université Paris-SudUniversité Paris-Saclay 1, avenue de la Terrasse Gif-sur-Yvette 91198 France
| |
Collapse
|
6
|
Barce Ferro CT, dos Santos BF, da Silva CDG, Brand G, da Silva BAL, de Campos Domingues NL. Review of the Syntheses and Activities of Some Sulfur-Containing Drugs. Curr Org Synth 2020; 17:192-210. [DOI: 10.2174/1570179417666200212113412] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Revised: 12/06/2019] [Accepted: 12/14/2019] [Indexed: 11/22/2022]
Abstract
Background:
Sulfur-containing compounds represent an important class of chemical compounds due
to their wide range of biological and pharmaceutical properties. Moreover, sulfur-containing compounds may be
applied in other fields, such as biological, organic, and materials chemistry. Several studies on the activities of
sulfur compounds have already proven their anti-inflammatory properties and use to treat diseases, such as
Alzheimer’s, Parkinson’s, and HIV. Moreover, examples of sulfur-containing compounds include dapsone,
quetiapine, penicillin, probucol, and nelfinavir, which are important drugs with known activities.
Objective:
This review will focus on the synthesis and application of some sulfur-containing compounds used to
treat several diseases, as well as promising new drug candidates.
Results:
Due to the variety of compounds containing C-S bonds, we have reviewed the different synthetic
routes used toward the synthesis of sulfur-containing drugs and other compounds.
Collapse
Affiliation(s)
- Criscieli Taynara Barce Ferro
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| | - Beatriz Fuzinato dos Santos
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| | - Caren Daniele Galeano da Silva
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| | - George Brand
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| | - Beatriz Amaral Lopes da Silva
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| | - Nelson Luís de Campos Domingues
- Faculty of Exact Sciences and Technology, Organic Catalysis and Biocatalysis Laboratory – (LACOB), Federal University of Grande Dourados – UFGD, Dourados/MS, Brazil
| |
Collapse
|
7
|
Xu H, Gu Y, Zhang S, Xiong H, Ma F, Lu F, Ji Q, Liu L, Ma P, Hou W, Yang G, Lerner RA. A Chemistry for Incorporation of Selenium into DNA‐Encoded Libraries. Angew Chem Int Ed Engl 2020; 59:13273-13280. [DOI: 10.1002/anie.202003595] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Indexed: 12/18/2022]
Affiliation(s)
- Hongtao Xu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Yuang Gu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
- School of Life Science and Technology ShanghaiTech University 201210 Shanghai China
- Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 China
- University of Chinese Academy of Sciences Beijing 100049 China
| | - Shuning Zhang
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
- School of Life Science and Technology ShanghaiTech University 201210 Shanghai China
- Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 China
- University of Chinese Academy of Sciences Beijing 100049 China
| | - Huan Xiong
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Fei Ma
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Fengping Lu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Qun Ji
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Lili Liu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Peixiang Ma
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Wei Hou
- College of Pharmaceutical Science Institute of Drug Development & Chemical Biology Zhejiang University of Technology Hangzhou 310014 China
| | - Guang Yang
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Richard A. Lerner
- Department of Chemistry Scripps Research Institute La Jolla CA 92037 USA
| |
Collapse
|
8
|
Xu H, Gu Y, Zhang S, Xiong H, Ma F, Lu F, Ji Q, Liu L, Ma P, Hou W, Yang G, Lerner RA. A Chemistry for Incorporation of Selenium into DNA‐Encoded Libraries. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202003595] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Hongtao Xu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Yuang Gu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
- School of Life Science and Technology ShanghaiTech University 201210 Shanghai China
- Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 China
- University of Chinese Academy of Sciences Beijing 100049 China
| | - Shuning Zhang
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
- School of Life Science and Technology ShanghaiTech University 201210 Shanghai China
- Institute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 China
- University of Chinese Academy of Sciences Beijing 100049 China
| | - Huan Xiong
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Fei Ma
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Fengping Lu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Qun Ji
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Lili Liu
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Peixiang Ma
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Wei Hou
- College of Pharmaceutical Science Institute of Drug Development & Chemical Biology Zhejiang University of Technology Hangzhou 310014 China
| | - Guang Yang
- Shanghai Institute for Advanced Immunochemical Studies ShanghaiTech University 201210 Shanghai China
| | - Richard A. Lerner
- Department of Chemistry Scripps Research Institute La Jolla CA 92037 USA
| |
Collapse
|
9
|
Garcia SN, Guedes RC, Marques MM. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. Curr Med Chem 2020; 26:7285-7322. [PMID: 30543165 DOI: 10.2174/0929867326666181213092652] [Citation(s) in RCA: 122] [Impact Index Per Article: 30.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Revised: 10/26/2018] [Accepted: 11/06/2018] [Indexed: 12/24/2022]
Abstract
Glycolysis is a tightly regulated process in which several enzymes, such as Hexokinases (HKs), play crucial roles. Cancer cells are characterized by specific expression levels of several isoenzymes in different metabolic pathways and these features offer possibilities for therapeutic interventions. Overexpression of HKs (mostly of the HK2 isoform) have been consistently reported in numerous types of cancer. Moreover, deletion of HK2 has been shown to decrease cancer cell proliferation without explicit side effects in animal models, which suggests that targeting HK2 is a viable strategy for cancer therapy. HK2 inhibition causes a substantial decrease of glycolysis that affects multiple pathways of central metabolism and also destabilizes the mitochondrial outer membrane, ultimately enhancing cell death. Although glycolysis inhibition has met limited success, partly due to low selectivity for specific isoforms and excessive side effects of the reported HK inhibitors, there is ample ground for progress. The current review is focused on HK2 inhibition, envisaging the development of potent and selective anticancer agents. The information on function, expression, and activity of HKs is presented, along with their structures, known inhibitors, and reported effects of HK2 ablation/inhibition. The structural features of the different isozymes are discussed, aiming to stimulate a more rational approach to the design of selective HK2 inhibitors with appropriate drug-like properties. Particular attention is dedicated to a structural and sequence comparison of the structurally similar HK1 and HK2 isoforms, aiming to unveil differences that could be explored therapeutically. Finally, several additional catalytic- and non-catalytic roles on different pathways and diseases, recently attributed to HK2, are reviewed and their implications briefly discussed.
Collapse
Affiliation(s)
- Sara N Garcia
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.,iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal
| | - Rita C Guedes
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal
| | - M Matilde Marques
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal
| |
Collapse
|
10
|
Begini F, Krasowska D, Jasiak A, Drabowicz J, Santi C, Sancineto L. Continuous flow synthesis of 2,2′-diselenobis(benzoic acid) and derivatives. REACT CHEM ENG 2020. [DOI: 10.1039/d0re00012d] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
The continuous flow synthesis of the key building block 2,2′-diselenobis(benzoic acid) (DSBA) and its analogues is herein reported.
Collapse
Affiliation(s)
- Francesca Begini
- Division of Organic Chemistry
- Centre of Molecular and Macromolecular Studies
- Polish Academy of Sciences
- Lodz
- Poland
| | - Dorota Krasowska
- Division of Organic Chemistry
- Centre of Molecular and Macromolecular Studies
- Polish Academy of Sciences
- Lodz
- Poland
| | - Aleksandra Jasiak
- Division of Organic Chemistry
- Centre of Molecular and Macromolecular Studies
- Polish Academy of Sciences
- Lodz
- Poland
| | - Jozef Drabowicz
- Division of Organic Chemistry
- Centre of Molecular and Macromolecular Studies
- Polish Academy of Sciences
- Lodz
- Poland
| | - Claudio Santi
- Department of Pharmaceutical Sciences
- University of Perugia
- Group of Catalysis, Synthesis and Organic Green Chemistry
- 06123 Perugia
- Italy
| | - Luca Sancineto
- Division of Organic Chemistry
- Centre of Molecular and Macromolecular Studies
- Polish Academy of Sciences
- Lodz
- Poland
| |
Collapse
|
11
|
Ruberte AC, Sanmartin C, Aydillo C, Sharma AK, Plano D. Development and Therapeutic Potential of Selenazo Compounds. J Med Chem 2019; 63:1473-1489. [PMID: 31638805 DOI: 10.1021/acs.jmedchem.9b01152] [Citation(s) in RCA: 63] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, antifungal, antiparasitic, and neuroprotective effects. Specifically, selenazo compounds have received great attention owing to their chemical properties, pharmaceutical applications, and low toxicity. In this Perspective, we compile extensive literature evidence with the description and discussion of the most recent advances in different selenazo and selenadiazo motifs as potential pharmacological candidates. We also provide some perspectives on the challenges and future directions in the advancement of these selenazo compounds, each of which could generate drug candidates for various diseases.
Collapse
Affiliation(s)
- Ana Carolina Ruberte
- Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición , Universidad de Navarra , Irunlarrea 1 , E-31008 Pamplona , Spain
| | - Carmen Sanmartin
- Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición , Universidad de Navarra , Irunlarrea 1 , E-31008 Pamplona , Spain
| | - Carlos Aydillo
- Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición , Universidad de Navarra , Irunlarrea 1 , E-31008 Pamplona , Spain
| | - Arun K Sharma
- Department of Pharmacology, Penn State Cancer Institute, CH72 , Penn State College of Medicine , 500 University Drive , Hershey , Pennsylvania 17033 , United States
| | - Daniel Plano
- Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición , Universidad de Navarra , Irunlarrea 1 , E-31008 Pamplona , Spain.,Department of Pharmacology, Penn State Cancer Institute, CH72 , Penn State College of Medicine , 500 University Drive , Hershey , Pennsylvania 17033 , United States
| |
Collapse
|
12
|
Orth N, Scheitler A, Josef V, Franke A, Zahl A, Ivanović‐Burmazović I. Synthesis of a Hybrid between SOD Mimetic and Ebselen to Target Oxidative Stress. Eur J Inorg Chem 2019. [DOI: 10.1002/ejic.201900407] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Nicole Orth
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| | - Andreas Scheitler
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| | - Verena Josef
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| | - Alicja Franke
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| | - Achim Zahl
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| | - Ivana Ivanović‐Burmazović
- Department of Chemistry and Pharmacy University of Erlangen‐Nuremberg Egerlandstrasse 1 91058 Erlangen Germany
| |
Collapse
|
13
|
Leroux F, Bosc D, Beghyn T, Hermant P, Warenghem S, Landry V, Pottiez V, Guillaume V, Charton J, Herledan A, Urata S, Liang W, Sheng L, Tang WJ, Deprez B, Deprez-Poulain R. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. Eur J Med Chem 2019; 179:557-566. [PMID: 31276900 DOI: 10.1016/j.ejmech.2019.06.057] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Revised: 06/18/2019] [Accepted: 06/19/2019] [Indexed: 12/15/2022]
Abstract
Insulin-degrading enzyme, IDE, is a metalloprotease implicated in the metabolism of key peptides such as insulin, glucagon, β-amyloid peptide. Recent studies have pointed out its broader role in the cell physiology. In order to identify new drug-like inhibitors of IDE with optimal pharmacokinetic properties to probe its multiple roles, we ran a high-throughput drug repurposing screening. Ebselen, cefmetazole and rabeprazole were identified as reversible inhibitors of IDE. Ebselen is the most potent inhibitor (IC50(insulin) = 14 nM). The molecular mode of action of ebselen was investigated by biophysical methods. We show that ebselen induces the disorder of the IDE catalytic cleft, which significantly differs from the previously reported IDE inhibitors. IDE inhibition by ebselen can explain some of its reported activities in metabolism as well as in neuroprotection.
Collapse
Affiliation(s)
- Florence Leroux
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Damien Bosc
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | | | - Paul Hermant
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Sandrine Warenghem
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Valérie Landry
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Virginie Pottiez
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Valentin Guillaume
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Julie Charton
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France
| | - Adrien Herledan
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France
| | - Sarah Urata
- Department of Medicine, University of California at San Diego, CA 92093, La Jolla, United States
| | - Wenguang Liang
- Ben-May Institute for Cancer Research, The University of Chicago, IL 60637, Chicago, United States
| | - Li Sheng
- Department of Medicine, University of California at San Diego, CA 92093, La Jolla, United States
| | - Wei-Jen Tang
- Ben-May Institute for Cancer Research, The University of Chicago, IL 60637, Chicago, United States
| | - Benoit Deprez
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; APTEEUS, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France
| | - Rebecca Deprez-Poulain
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177, Drugs and Molecules for Living Systems, F-59000, Lille, France; European Genomic Institute for Diabetes, EGID, University of Lille, F-59000, France; Institut Universitaire de France, F- 75231, Paris, France.
| |
Collapse
|
14
|
Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo. Bioorg Chem 2019; 84:192-201. [DOI: 10.1016/j.bioorg.2018.11.035] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2018] [Revised: 11/19/2018] [Accepted: 11/20/2018] [Indexed: 11/20/2022]
|
15
|
The Influence of O/S Exchange on the Biocatalytical Activity of Benzisoselenazol-3(2H)-ones. Catalysts 2018. [DOI: 10.3390/catal8110493] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The crucial feature of organoselenium compounds, when considering them as promising drug candidates in cancer therapy, is their unique ability to alter the cellular redox regulations. Organic Se-molecules continue to demonstrate a positive therapeutic effect both in cancer prevention—as antioxidants, and treatment—as prooxidants. The growing interest in this field of research highlights the need to search for particular pharmacophore motifs, which could enhance the efficiency and selectivity, and decrease the toxicity of potential anticancer agents. Herein, a series of redox-active organoselenium derivatives—N-functionalized benzisoselenazol-3(2H)-thiones, has been designed and synthetized. A new synthetic pathway, with the application of Lawesson’s reagent, has been developed and efficiently applied. The key steps involving microwave irradiation facilitated performing the reaction in solvent-free conditions, shortening the reaction time and significantly improving the overall yield of the process. Six N-alkyl derivatives have been obtained and tested as antioxidant catalysts and anti-proliferative agents. The N-propyl benzisoselenazol-3(2H)-thione was the best peroxide scavenger and the N-cyclohexyl derivative exhibited the best cytotoxic activity towards prostate cancer cell line DU145.
Collapse
|
16
|
Jin WB, Xu C, Cheng Q, Qi XL, Gao W, Zheng Z, Chan EWC, Leung YC, Chan TH, Wong KY, Chen S, Chan KF. Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2H)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1. Eur J Med Chem 2018; 155:285-302. [PMID: 29894943 DOI: 10.1016/j.ejmech.2018.06.007] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Revised: 04/11/2018] [Accepted: 06/01/2018] [Indexed: 10/14/2022]
Abstract
The worldwide prevalence of NDM-1-producing bacteria has drastically undermined the clinical efficacy of the last line antibiotic of carbapenems, prompting a need to devise effective strategy to preserve their clinical value. Our previous studies have shown that ebselen can restore the efficacy of meropenem against a laboratory strain that produces NDM-1. Here we report the construction of a focused compound library of 1,2-benzisoselenazol-3(2H)-one derivatives which comprise a total of forty-six candidate compounds. The structure-activity relationship of these compounds and their potential to serve as an adjuvant to enhance the antimicrobial efficacy of meropenem against a collection of clinical NDM-1-producing carbapenem-resistant Enterobacteriaceae isolates was examined. Drug combination assays indicated that these derivatives exhibited synergistic antimicrobial activity when used along with meropenem, effectively restoring the activity of carbapenems against the resistant strains tested in a Galleria mellonella larvae in vivo infection model. The mode of inhibition of one compound, namely 11_a38, which was depicted when tested on the purified NDM-1 enzyme, indicated that it could covalently bind to the enzyme and displaced one zinc ion from the active site. Overall, this study provides a novel 1,2-benzisoselenazol-3(2H)-one scaffold that exhibits strong synergistic antimicrobial activity with carbapenems, and low cytotoxicity. The prospect of application of such compounds as carbapenem adjuvants warrants further evaluation.
Collapse
Affiliation(s)
- Wen Bin Jin
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Chen Xu
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Qipeng Cheng
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Xiao Lin Qi
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Wei Gao
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Zhiwei Zheng
- Shenzhen Key Laboratory for Food Biological Safety Control, Food Safety and Technology Research Centre, The Hong Kong PolyU Shenzhen Research Institute, Shenzhen, China
| | - Edward W C Chan
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Yun-Chung Leung
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Tak Hang Chan
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China; Department of Chemistry, McGill University, Montreal, Quebec, H3A 2K6, Canada
| | - Kwok-Yin Wong
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Sheng Chen
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China; Shenzhen Key Laboratory for Food Biological Safety Control, Food Safety and Technology Research Centre, The Hong Kong PolyU Shenzhen Research Institute, Shenzhen, China.
| | - Kin-Fai Chan
- State Key Laboratory of Chirosciences and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
| |
Collapse
|